Axion Biosystems

Axion BioSystems creates tools for understanding human heart and brain activity. The company’s novel platform is a proprietary microelectronic system that enables precise manipulation of human cells and tissue.

Axion’s flagship product, the Maestro, is the first commercially available multiple micro electrode array (MEA). This in vitro tool, which models brain activity in a dish, is used to evaluate drug toxicity, develop lead compounds and create phenotypic models.

Axion’s tools offer a range of biomedical applications — life science instrumentation, medical diagnostics and implantable devices — with relevance to the pharmaceutical and biotech industries and academic and government research.